JP2024544067A5 - - Google Patents

Info

Publication number
JP2024544067A5
JP2024544067A5 JP2024532266A JP2024532266A JP2024544067A5 JP 2024544067 A5 JP2024544067 A5 JP 2024544067A5 JP 2024532266 A JP2024532266 A JP 2024532266A JP 2024532266 A JP2024532266 A JP 2024532266A JP 2024544067 A5 JP2024544067 A5 JP 2024544067A5
Authority
JP
Japan
Prior art keywords
chemically modified
modified oligonucleotide
oligonucleotide according
bonds
nucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024532266A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024544067A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/083711 external-priority patent/WO2023099494A1/en
Publication of JP2024544067A publication Critical patent/JP2024544067A/ja
Publication of JP2024544067A5 publication Critical patent/JP2024544067A5/ja
Pending legal-status Critical Current

Links

JP2024532266A 2021-11-30 2022-11-29 Rnaに作用する内因性アデノシンデアミナーゼ(adar)による効率的および正確なrna編集のためのアンチセンスオリゴヌクレオチド(aso) Pending JP2024544067A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21211372 2021-11-30
EP21211372.4 2021-11-30
PCT/EP2022/083711 WO2023099494A1 (en) 2021-11-30 2022-11-29 Antisense oligonucleotides (aso) for efficient and precise rna editing with endogenous adenosine deaminase acting on rna (adar)

Publications (2)

Publication Number Publication Date
JP2024544067A JP2024544067A (ja) 2024-11-27
JP2024544067A5 true JP2024544067A5 (cg-RX-API-DMAC10.html) 2025-12-11

Family

ID=78820190

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024532266A Pending JP2024544067A (ja) 2021-11-30 2022-11-29 Rnaに作用する内因性アデノシンデアミナーゼ(adar)による効率的および正確なrna編集のためのアンチセンスオリゴヌクレオチド(aso)

Country Status (9)

Country Link
US (1) US20230235329A1 (cg-RX-API-DMAC10.html)
EP (1) EP4441216A1 (cg-RX-API-DMAC10.html)
JP (1) JP2024544067A (cg-RX-API-DMAC10.html)
KR (1) KR20240111752A (cg-RX-API-DMAC10.html)
CN (1) CN118355119A (cg-RX-API-DMAC10.html)
AU (1) AU2022399905A1 (cg-RX-API-DMAC10.html)
CA (1) CA3238033A1 (cg-RX-API-DMAC10.html)
IL (1) IL312762A (cg-RX-API-DMAC10.html)
WO (1) WO2023099494A1 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250101418A1 (en) * 2022-11-30 2025-03-27 Eberhard-Karls-Universität-Tübingen Chemically modified antisense oligonucleotides (asos) and compositions comprising the same for rna editing
EP4762176A1 (en) * 2023-08-15 2026-06-24 Airna Corporation Chemically modified antisense oligonucleotides (asos) and compositions for rna editing
WO2025073902A1 (en) * 2023-10-06 2025-04-10 Eberhard Karls Universität Tübingen Chemical and sequence optimisation of antisense oligonucleotides for adar-mediated rna editing
WO2025172372A1 (en) 2024-02-12 2025-08-21 Airna Corporation Conjugate for targeted delivery of an antisense oligonucleotide
WO2025242018A1 (zh) * 2024-05-20 2025-11-27 时夕(广州)生物科技有限公司 一种经修饰的向导agRNA

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018041973A1 (en) * 2016-09-01 2018-03-08 Proqr Therapeutics Ii B.V. Chemically modified single-stranded rna-editing oligonucleotides
WO2020001793A1 (en) 2018-06-29 2020-01-02 Eberhard-Karls-Universität Tübingen Artificial nucleic acids for rna editing
US20230039928A1 (en) * 2019-12-23 2023-02-09 Proqr Therapeutics Ii B.V. Antisense oligonucleotides for nucleotide deamination in the treatment of Stargardt disease

Similar Documents

Publication Publication Date Title
JP2025165976A5 (cg-RX-API-DMAC10.html)
JP2021512629A5 (cg-RX-API-DMAC10.html)
JP2022550915A5 (cg-RX-API-DMAC10.html)
JP2024038326A5 (cg-RX-API-DMAC10.html)
AU2020290517B2 (en) Antisense RNA editing oligonucleotides comprising cytidine analogs
US5696253A (en) Polynucleoside chain with 3'→5' guanidyl linkages
DE60038495T2 (de) Oligonukleotid n3'-p5' thiophosphoramidate: ihre synthese und verwendung
JP2024038327A5 (cg-RX-API-DMAC10.html)
JP2024088642A5 (cg-RX-API-DMAC10.html)
US7989603B2 (en) 2′-arabino-fluorooligonucleotide N3′-P5′ phosphoramidates: their synthesis and use
US11584773B2 (en) Phosphorous protecting groups and methods of preparation and use thereof
US5969116A (en) Nucleosides and oligonucleotides having 2'-ether groups
JP2022532169A5 (cg-RX-API-DMAC10.html)
US20170247695A1 (en) Isotopologues of smad7 antisense oligonucleotides
JP2022527814A5 (cg-RX-API-DMAC10.html)
JPH07300493A (ja) 2′−エーテル基を有する、ヌクレオシド及びオリゴヌクレオチド
JP2001103987A (ja) 高いキラル純度のホスホロチオエート結合を有するオリゴヌクレオチド
JPH0813274B2 (ja) 遺伝子発現を検出及び変調する糖修飾されたオリゴヌクレオチド
JPH06511492A (ja) キラルリン結合を有するオリゴヌクレオチド
JP2024545602A5 (cg-RX-API-DMAC10.html)
JP2021511072A5 (cg-RX-API-DMAC10.html)
JP2024543963A5 (cg-RX-API-DMAC10.html)
JP2024544067A (ja) Rnaに作用する内因性アデノシンデアミナーゼ(adar)による効率的および正確なrna編集のためのアンチセンスオリゴヌクレオチド(aso)
DE69725440T2 (de) 2-substituierte nukleosid- und oligonukleotid- derivate
JP2023526057A5 (cg-RX-API-DMAC10.html)